Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Crisafulli (Pavullo (MO), Italy). Role of non-cystic fibrosis bronchiectasis in hospitalized patients with acute exacerbation of COPD. 4959

Member's Comments

No comment yet.

Related content which might interest you: Influence of bronchiectasis in patients hospitalized due to acute exacerbation of COPD. Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Assessing response to treatment of exacerbations of bronchiectasis in adults Source: Eur Respir J 2009; 33: 312-318 Year: 2009 Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis Source: ERJ Open Res, 4 (1) 00111-2017; 10.1183/23120541.00111-2017 Year: 2018 HRCT features in patients with severe asthma and non-cystic fibrosis bronchiectasis. Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Role of colonization on inflammation in COPD patients with bronchiectasis Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Calorie-intake in patients hospitalized for an acute COPD exacerbation Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer Year: 2007 The prevalence of non-cystic fibrosis bronchiectasis in a pediatric respiratory unit Source: International Congress 2018 – Orphan diseases in children Year: 2018 Occurrence and impact of bronchiectasis in patients with COPD Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Differences of acute exacerbations in idiopathic pulmonary fibrosis compared to other fibrotic lung diseases Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Noninvasive ventilation in acute respiratory failure caused by non-cystic fibrosis bronchiectasis and chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: notable points Year: 2015 Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroids Source: Breathe, 16 (3) 200086; 10.1183/20734735.0086-2020 Year: 2020 Patients hospitalised with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Acute exacerbation of idiopathic pulmonary fibrosis Source: Eur Respir J 2004; 23: 792 Year: 2004 Asymmetry in acute exacerbation of idiopathic pulmonary fibrosis Source: ERJ Open Res, 3 (2) 00036-2016; 10.1183/23120541.00036-2016 Year: 2017 Defining the contribution of emphysema and chronic bronchitis in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 539s Year: 2003 Effect of azithromycin on FEV1 and exacerbation frequency in adult non-cystic fibrosis bronchiectasis Source: Eur Respir J 2007; 30: Suppl. 51, 528s Year: 2007 GORD/PPI and exacerbations in adults with bronchiectasis Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Predictive factors for severe pulmonary exacerbations in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006 Pulmonary rehabilitation of patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010